10
Annex II
Scientific conclusions
11
Scientific conclusions
Ethinylestradiol is a synthetic estrogen while dienogest is a nortestosterone derivative which uni
15.12.2017
Datei
PD
27 September 2013
EMA/750624/2013
Assessment report
Ergot derivatives containing medicinal products
International Non-proprietary Name: dihydroergocristine
Procedure number: EMEA/H/A-31/132
15.12.2017
Datei
PD
27 September 2013
EMA/750625/2013
Assessment report
Ergot derivatives containing medicinal products
International Non-proprietary Name: dihydroergocryptine/caffeine
Procedure number: EMEA/H
15.12.2017
Datei
PD
27 September 2013
EMA/750626/2013
CHMP referral assessment report
Ergot derivatives containing medicinal products
International Non-proprietary Name: dihydroergotamine
Procedure number:
15.12.2017
Datei
PD
18 December 2013
EMA/750630/2013
Assessment report
Ergot derivatives containing medicinal products
International Non-proprietary Name: dihydroergotoxine
Procedure number: EMEA/H/A-31/1325
15.12.2017
Datei
PD
27 September 2013
EMA/750632/2013
Assessment report
Ergot derivatives containing medicinal products
International Non-proprietary Name: nicergoline
Procedure number: EMEA/H/A-31/1325
R
15.12.2017
Datei
PD
Annex III
Amendments to relevant sections of the summaries of product
characteristics and package leaflets
11
A. Summary of Product Characteristics
4.1 Therapeutic indications
15.12.2017
Datei
PD
Annex III
Amendments to relevant sections of the summaries of product
characteristics and package leaflets
8
A. Summary of Product Characteristics
4.1 Therapeutic indications
[
15.12.2017
Datei
PD
Annex III
Amendments to relevant sections of the summaries of product
characteristics and package leaflets
16
A. Summary of Product Characteristics
4.1 Therapeutic indications
[t
15.12.2017
Datei
PD
Annex III
Amendments to relevant sections of the summaries of product
characteristics and package leaflets
15
A. Summary of Product Characteristics
4.1 Therapeutic indications
[t
15.12.2017
Datei
PD
